SINPAIN

A game changer for the treatment of osteoarthritis: a cost effective combined advanced therapy to treat knee osteoarthritis


Description

Osteoarthritis is the most common chronic joint disorder worldwide, but there is no efficient treatment so far. Therefore, new medications are needed to improve the quality of life for those affected and reduce the high costs associated with this disease. Taking advantage of the explosion of RNA technologies in the last years, the SINPAIN project sets out to fill this gap by developing a safe, efficient and cost-effective small interfering RNA (siRNA)-based therapy combining RNA technology with improved intraarticular hyaluronic acid-based knee viscosupplement (IA-HA) containing tissue engineering tools, such as nanocarriers. Ultimately, the team aims to develop more personalised diagnostic and treatment options for different stages of osteoarthritis.

Coordinator
Dr Damien Dupin
Fundación CIDETEC
Phone: +34 943 30 90 22
Email
Programme
Horizon Europe & sub-programmes
Duration
54 months (May 2022 - October 2026)
Project funding
€ 5,387,557.00
Project partners
12
Project website
https://www.osteoarthritis-sinpain.eu/
Download Factsheet
Your contact
Janine Jost
Senior Project Manager
Phone: +49 6894 3881331
E-mail
About Eurice

Eurice offers knowledge-based consultancy services in project and innovation management.

Eurice Head Office
Heinrich-Hertz-Allee 1
66386 St. Ingbert
Germany
Phone: +49 6894 388130
Email
Eurice Berlin
Alt-Reinickendorf 25
13407 Berlin
Germany
Phone: +49 30 374415840
Email